These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4801462)

  • 1. [Proceedings: Comparative animal experiments on the effectivity of various endocrine therapeutic methods in hormone dependent breast carcinoma].
    Schulz KD; Ahrens J
    Arch Gynakol; 1973 Sep; 214(1):296-7. PubMed ID: 4801462
    [No Abstract]   [Full Text] [Related]  

  • 2. Endocrine and metabolic diseases: Treatment of infertility and menopausal symptoms.
    Klopper A
    Br Med J; 1976 Aug; 2(6032):414-6. PubMed ID: 779927
    [No Abstract]   [Full Text] [Related]  

  • 3. Microscopic and ultrastructural changes of hormone-dependent rat mammary cancer treated with "anti-hormones".
    Pape C; Ahrens J; Schulz KD
    Acta Endocrinol Suppl (Copenh); 1973; 173():151. PubMed ID: 4542084
    [No Abstract]   [Full Text] [Related]  

  • 4. [Proceedings: Biochemical studies on cis-clomiphene action mechanism in estrogen dependent breast carcinoma of the rat].
    Wüstenberg B; Schulz KD
    Arch Gynakol; 1973 Sep; 214(1):295-6. PubMed ID: 4801461
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical trial of 2-Br- -ergocryptine (CB154) in advanced breast cancer.
    Eur J Cancer (1965); 1972 Apr; 8(2):155-6. PubMed ID: 4561333
    [No Abstract]   [Full Text] [Related]  

  • 6. [Exploration and treatment of functional metrorrhagia and of menopause].
    Lambotte R
    Rev Med Liege; 1973 Feb; 28(4):124-30. PubMed ID: 4800008
    [No Abstract]   [Full Text] [Related]  

  • 7. The inhibition of hormone-dependent rat mammary cancer by clomiphene isomers.
    Wüstenberg B; Schulz KD
    Acta Endocrinol Suppl (Copenh); 1973; 173():66. PubMed ID: 4542141
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-lasting anti-tremor induced by 2-Br-alpha-ergocryptine in monkeys.
    Miyamoto T; Battista A; Goldstein M; Fuxe K
    J Pharm Pharmacol; 1974 Jun; 26(6):452-4. PubMed ID: 4154991
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative effects of hypophysectomy, ergocornine and ergocornine-reserpine treatments on rat mammary carcinoma.
    Welsch CW; Iturri G; Meites J
    Int J Cancer; 1973 Jul; 12(1):206-12. PubMed ID: 4790704
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of 2-Br-alpha-Ergocryptine, L-dopa and cyclic imides on serum prolactin in postmenopausal women.
    Rozencweig M; Heuson JC; Bila S; L'Hermite M; Robyn C
    Eur J Cancer (1965); 1973 Sep; 9(9):657-64. PubMed ID: 4803232
    [No Abstract]   [Full Text] [Related]  

  • 11. Cycle pattern and pregnancy rate following combined clomiphene-estrogen therapy.
    Insler V; Zakut H; Serr DM
    Obstet Gynecol; 1973 Apr; 41(4):602-7. PubMed ID: 4735315
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term treatment of galactorrhoea and hypogonadism with bromocriptine.
    Thorner MO; McNeilly AS; Hagan C; Besser GM
    Br Med J; 1974 May; 2(5916):419-22. PubMed ID: 4600593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of ethinyl estradiol to reverse the antiestrogenic effects of clomiphene citrate in patients undergoing intrauterine insemination: a comparative, randomized study.
    Gerli S; Gholami H; Manna C; Di Frega AS; Vitiello C; Unfer V
    Fertil Steril; 2000 Jan; 73(1):85-9. PubMed ID: 10632418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ergocornine on transplanted mammary tumor growth and pituitary prolactin level in BALB/c mice.
    Singh DV; Meites J; Halmi L; Kortright KH; Brennan MJ
    J Natl Cancer Inst; 1972 Jun; 48(6):1727-31. PubMed ID: 5056256
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of galactorrhea-amenorrhea syndrome with Br-ergocryptine (CB 154): restoration of ovulatory function and fertility.
    Varga L; Wenner R; Del Pozo E
    Am J Obstet Gynecol; 1973 Sep; 117(1):75-9. PubMed ID: 4722381
    [No Abstract]   [Full Text] [Related]  

  • 16. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP
    J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced regression of DMBA-induced mammary cancers in rats by combination of ergocornine with ovariectomy or high doses of estrogen.
    Quadri SK; Kledzik GS; Meites J
    Cancer Res; 1974 Mar; 34(3):499-501. PubMed ID: 4812257
    [No Abstract]   [Full Text] [Related]  

  • 18. Regression of spontaneous mammary tumors in rats by ergot drugs.
    Quadri SK; Meites J
    Proc Soc Exp Biol Med; 1971 Dec; 138(3):999-1001. PubMed ID: 5131642
    [No Abstract]   [Full Text] [Related]  

  • 19. Quinestrol therapy in hypomucorrhea due to clomiphene.
    Sharf M; Graff G; Kuzminsky T
    Am J Obstet Gynecol; 1971 Jun; 110(3):423-4. PubMed ID: 5088384
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental chemotherapy of mammary neoplasms. A review].
    Schönenberger H; Kranzfelder G; Hoffmann E; Egginger G; Schmitt H; Taneja AK
    Pharmazie; 1976; 31(9):590-7. PubMed ID: 798208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.